• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on: Reduced dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis: JTH 2018 Jul; 16(7): 1288-95.

作者信息

Herold Joerg, Bauersachs Rupert

机构信息

Department of Vascular Medicine- Angiology, Klinikum Darmstadt GmbH, Darmstadt, Germany.

出版信息

J Thromb Haemost. 2021 Sep;19(9):2357-2358. doi: 10.1111/jth.15426.

DOI:10.1111/jth.15426
PMID:34435433
Abstract
摘要

相似文献

1
Comment on: Reduced dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis: JTH 2018 Jul; 16(7): 1288-95.评论：低剂量直接口服抗凝剂（DOACs）用于静脉血栓栓塞症的延长治疗：一项系统评价和荟萃分析。《血栓与止血杂志》：JTH 2018年7月；16(7): 1288 - 1295。
J Thromb Haemost. 2021 Sep;19(9):2357-2358. doi: 10.1111/jth.15426.
2
Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.哪些无诱因静脉血栓栓塞症患者应接受直接口服抗凝剂的延长抗凝治疗？系统评价、网络荟萃分析和决策分析。
J Eval Clin Pract. 2020 Feb;26(1):7-17. doi: 10.1111/jep.13194. Epub 2019 Jun 12.
3
Reduced-dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta-analysis-Response to Commentary.低剂量直接口服抗凝剂（DOACs）用于静脉血栓栓塞症的延长治疗：一项系统评价与荟萃分析——对评论的回应
J Thromb Haemost. 2021 Sep;19(9):2359-2360. doi: 10.1111/jth.15427.
4
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.癌症患者静脉血栓栓塞症长期治疗的抗凝治疗
Cochrane Database Syst Rev. 2018 Jun 19;6(6):CD006650. doi: 10.1002/14651858.CD006650.pub5.
5
Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis.在静脉血栓栓塞症的延长治疗中使用低剂量直接口服抗凝剂：系统评价和荟萃分析。
J Thromb Haemost. 2018 Jul;16(7):1288-1295. doi: 10.1111/jth.14156. Epub 2018 Jun 17.
6
Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.接受直接口服抗凝剂进行静脉血栓栓塞初始和延长治疗的患者复发性血栓栓塞和出血的病死率：一项系统评价
J Cardiovasc Pharmacol Ther. 2015 Sep;20(5):490-500. doi: 10.1177/1074248415575154. Epub 2015 Mar 23.
7
Thrombophilia testing in the era of direct oral anticoagulants.直接口服抗凝剂时代的血栓形成倾向检测。
Clin Med (Lond). 2021 Sep;21(5):e487-e491. doi: 10.7861/clinmed.2020-1008. Epub 2021 Sep 7.
8
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.在静脉血栓栓塞患者中使用直接口服抗凝剂或维生素 K 拮抗剂治疗期间的出血和血栓并发症，包括在前瞻性、观察性 START2 注册研究中。
BMJ Open. 2020 Nov 27;10(11):e040449. doi: 10.1136/bmjopen-2020-040449.
9
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.直接口服抗凝剂在静脉血栓栓塞和血栓形成倾向患者中的应用：系统评价和荟萃分析。
J Thromb Haemost. 2019 Apr;17(4):645-656. doi: 10.1111/jth.14398. Epub 2019 Feb 25.
10
Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis.轻度至中度肝硬化患者使用直接口服抗凝剂的安全性：一项系统评价和荟萃分析。
J Thromb Thrombolysis. 2021 Oct;52(3):817-827. doi: 10.1007/s11239-021-02424-4. Epub 2021 Mar 16.

引用本文的文献

1
[Deep vein thrombosis and pulmonary embolism : Diagnosis and treatment].[深静脉血栓形成与肺栓塞：诊断与治疗]
Inn Med (Heidelb). 2022 Jun;63(6):601-611. doi: 10.1007/s00108-022-01349-1. Epub 2022 May 9.